Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

Selective inhibition of class I but not class IIb histone

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Frontiers Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism

Soluble epoxide hydrolase deficiency attenuates airway

PDF) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and

Cardiomyocyte-specific disruption of soluble epoxide hydrolase

TGF-β1 induces cardiac hypertrophic responses via PKC-dependent

Zuowen He's research works Tongji Hospital, Wuhan and other places

Inhibition of soluble epoxide hydrolase alleviates insulin

Cardiomyocyte-specific disruption of soluble epoxide hydrolase

Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical

Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic